论文部分内容阅读
作者收集1973～1976年确诊为急性非淋巴细胞性白血病成年患者112例,均为初治,其中男性52人,女性60人。诱导治疗:第一天,红比霉素1.5mg/kg静注,第1～5天为阿糖胞苷1.0mg/kg,每日二次静注,初次两个疗程之间间隔5天,如患者骨髓发生严重的增生低下,则以后适当延长间歇期。通过诱导治疗,有62人(55%)进入完全缓解期,这些患者在维持治疗时有42例随机地分为单独化疗组(CT组)和化疗免疫组(CIT组)。前者
The authors collected from 1973 to 1976 were diagnosed with acute non-lymphocytic leukemia in 112 cases of adult patients, all untreated, of which 52 males and 60 females. Induction treatment: the first day, intravenous injection of bisphenamine 1.5mg / kg, 1 to 5 days of cytarabine 1.0mg / kg, intravenous injection twice daily for the first time between the two courses of 5 days interval, If patients with severe bone marrow hyperplasia, then the appropriate extension of intermittent period. Thirty-two patients (55%) entered complete remission through induction therapy. Of these patients, 42 were randomly assigned to chemotherapy alone (CT group) and chemotherapy-immunized group (CIT group) during maintenance therapy. former